Lectenz Bio receives patent issuance from USPTO
The Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This expands the...
Read moreThe Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This expands the...
Read moreLectenz Bio’s Chief Scientific Officer and co-founder Lori Yang was recently interviewed by JLabs for her work on International...
Read moreLectenz Bio team was selected to participate as semi-finalists for the 2016 Thermo Fisher Scientific Innovation Day. This unique program is set up...
Read moreRESI (Redefining Early Stage Investments) seeks to bring together early stage life science companies with strategic investors in order to create...
Read moreLectenz Bio received Best Poster recognition at the 2016 Biomanufacturing Technology Summit. The team presented their work on the bioprocess...
Read moreGeorgia Bio (GaBio) announced Lectenz Bio’s CEO, Kausar Samli, as a recipient of the Emerging Leader Award for 2016. The award celebrates...
Read moreThe Lectenz Bio participated in the 2015-2016 Advanced Commercialization Track in the NIH Commercialization Accelerator Program (CAP). The NIH CAP...
Read moreLectenz Bio represented the state of Georgia at the BIO 2015 Summit in Philadelphia. This conference focuses on bringing together biotech’s top...
Read moreRobert Woods, professor of biochemistry and molecular biology, and chemistry, and researcher in the Complex Carbohydrate Research Center, earned...
Read more